About Fuh Hwa 15+ Yr Pharmaceuticals Bond ETF

00759B top holdings are Pfizer Investment Enterprises Pte. Ltd. 5.3% 19-MAY-2053 and AbbVie Inc. 4.25% 21-NOV-2049, occupying 3.46% and 3.27% of the portfolio correspondingly.

00759B last dividends amounted to 0.62 TWD. The quarter before, the issuer paid 0.66 TWD in dividends, which shows a 6.45% decrease.

00759B assets under management is ‪2.41 B‬ TWD. It's fallen 10.32% over the last month.

00759B fund flows account for 0.00 TWD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.

Yes, 00759B pays dividends to its holders with the dividend yield of 5.06%. The last dividend (Jun 17, 2025) amounted to 0.62 TWD. The dividends are paid quarterly.

00759B expense ratio is 0.51% meaning you'd have to pay 0.51% of your investment to help manage the fund.

00759B follows the Bloomberg Barclays US Corporate 15+ Year Pharmaceuticals Index - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

00759B invests in bonds.

00759B price has fallen by −9.64% over the last month, and its yearly performance shows a −9.72% decrease. See more dynamics on 00759B price chart.
NAV returns, another gauge of an ETF dynamics, have fallen by −9.77% over the last month, showed a −12.70% decrease in three-month performance and has decreased by −7.27% in a year.